BeStock  
Stocks › ABUS

Arbutus Biopharma ABUS

US equityMarket cap rank #3392
$4.08 −$0.21 (-4.96%)
Market open · Oct 8, 11:40 am ET · After hours $4.30 +0.23%
Open$4.22
Prev close$4.29
Day range$4.05 – $4.30
Volume1.62M
Market cap$807.76M
P/E (TTM)5.2
Dividend yield–

Earnings

Average move on report day±3.5%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+10.1%
Worst reaction-13.7%

Stock move on the day after each report

-4.5%2021/Q4+2.4%2022/Q1+3.3%2022/Q2-0.8%2022/Q3+0.0%2022/Q4+1.6%2023/Q1-1.0%2023/Q2-1.6%2023/Q3-2.8%2023/Q4-0.4%2024/Q1+1.1%2024/Q2-1.0%2024/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2024/Q36 Nov 2024Pre Market±13.4%-1.01%Within range
2024/Q21 Aug 2024Pre Market±16.4%+1.06%Within range
2024/Q12 May 2024Pre Market±14.4%-0.37%Within range
2023/Q429 Feb 2024Pre Market±24.3%-2.78%Within range
2023/Q37 Nov 2023Pre Market±16.0%-1.60%Within range
2023/Q23 Aug 2023Pre Market±12.0%-0.96%Within range
2023/Q14 May 2023Pre Market±23.9%+1.59%Within range
2022/Q42 Mar 2023Pre Market±33.6%+0.00%Within range
2022/Q39 Nov 2022Pre Market±30.2%-0.81%Within range
2022/Q24 Aug 2022Pre Market±19.3%+3.25%Within range
2022/Q15 May 2022Pre Market±18.0%+2.41%Within range
2021/Q43 Mar 2022Pre Market±24.1%-4.53%Within range
2021/Q34 Nov 2021Pre Market±22.2%+0.78%Within range
2021/Q25 Aug 2021Pre Market±25.5%+10.14%Within range
2021/Q15 May 2021Pre Market±27.3%-11.11%Within range
2020/Q44 Mar 2021Pre Market±39.6%-13.74%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q2, ended Jun 2026

Revenue$1.01M-90.6% YoY
Operating profit-$5.75M-400.6% YoY
Net profit-$5.14M-303.8% YoY
Diluted EPS-$0.03-400.0% YoY
Free cash flow-$6.02M+61.8% YoY
Operating cash flow-$6.02M

Revenue, last 8 quarters

$1.3MSep '24$1.6MDec '24$1.8MMar '25$10.7MJun '25$529.0KSep '25$1.1MDec '25$179.1MMar '26$1.0MJun '26

Net profit, last 8 quarters

$-19.7MSep '24$-12.5MDec '24$-24.5MMar '25$2.5MJun '25$-7.7MSep '25$-3.8MDec '25$169.7MMar '26$-5.1MJun '26

Profitability & balance sheet

Operating margin81.1%
Net margin84.2%
Return on equity89.6%
Return on assets81.1%
Return on invested capital88.0%
Current ratio81.42
Liabilities / assets5.6%
Cash & investments$92.63M
Total debt$0.00
Net cash (debt)$92.63M

Discussion

No comments yet — be the first to weigh in on ABUS.

Leave a comment

Scroll to Top